Biotech Values

[iwfal]

ICPT jumped again - probably as a result of the Q CC last night where the CEO pointed out that they have specific and strong results (with the same drug) in other indication (e.g. Crohns).

(Note: I didn't vet all the claims, but will say that I vetted some. Certainly would have been worthy of follow up when this was a $1.2B company -ng-)